Nicht kategorisiert

index.php edited ak.

Type 1 diabetes prevention: First young participant reaches turning point in POInT study

08.07.2020

Children participating in the type 1 diabetes prevention trial „POInT“ transfer from the first to the second phase of the study when turning three years old. Now the first participant from the study site in Dresden at the Center for Regenrative Therapies TU Dresden...

index.php edited ak.

Halftime: The world’s largest prevention study for type 1 diabetes in infants has reached an important milestone

31.01.2020

One of Europe’s largest type 1 diabetes research cooperations has passed a significant milestone: The international platform GPPAD (“The Global Platform for the Prevention of Autoimmune Diabetes”) has successfully included 520 babies across Europe in the type 1...

index.php edited ak.

6th GPPAD Investigator Meeting

17.10.2019

This time the international GPPAD team met in Warsaw to participate in workshops, to exchange on ongoing studies and to discuss future plans. During the three-day meeting the colleagues from Belgium, Germany, Great Britain, Sweden and Poland also visited the Medical...